AKT1 and neoplasm: The simultaneous activation of the phosphatidylinositol 3-kinase (PI3 K)/protein kinase B (AKT) and mitogen-activated protein kinases (MAPK) signalling pathways by AMY1 fosters a robust environment for tumour growth, resistance to apoptosis, and metastasis (78, 79).